Form 8-K - Current report:
SEC Accession No. 0001193125-24-272891
Filing Date
2024-12-09
Accepted
2024-12-09 07:39:09
Documents
54
Period of Report
2024-12-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d818014d8k.htm   iXBRL 8-K 32227
2 EX-99.1 d818014dex991.htm EX-99.1 16655
3 EX-99.2 d818014dex992.htm EX-99.2 42181
7 GRAPHIC g818014ex99_2p10g1.jpg GRAPHIC 208282
8 GRAPHIC g818014ex99_2p11g1.jpg GRAPHIC 262303
9 GRAPHIC g818014ex99_2p12g1.jpg GRAPHIC 253243
10 GRAPHIC g818014ex99_2p13g1.jpg GRAPHIC 235970
11 GRAPHIC g818014ex99_2p14g1.jpg GRAPHIC 239714
12 GRAPHIC g818014ex99_2p15g1.jpg GRAPHIC 233207
13 GRAPHIC g818014ex99_2p16g1.jpg GRAPHIC 244780
14 GRAPHIC g818014ex99_2p17g1.jpg GRAPHIC 258239
15 GRAPHIC g818014ex99_2p18g1.jpg GRAPHIC 195834
16 GRAPHIC g818014ex99_2p19g1.jpg GRAPHIC 196310
17 GRAPHIC g818014ex99_2p1g1.jpg GRAPHIC 257895
18 GRAPHIC g818014ex99_2p20g1.jpg GRAPHIC 191876
19 GRAPHIC g818014ex99_2p21g1.jpg GRAPHIC 172757
20 GRAPHIC g818014ex99_2p22g1.jpg GRAPHIC 201593
21 GRAPHIC g818014ex99_2p23g1.jpg GRAPHIC 208463
22 GRAPHIC g818014ex99_2p24g1.jpg GRAPHIC 295515
23 GRAPHIC g818014ex99_2p25g1.jpg GRAPHIC 230702
24 GRAPHIC g818014ex99_2p26g1.jpg GRAPHIC 179561
25 GRAPHIC g818014ex99_2p27g1.jpg GRAPHIC 166439
26 GRAPHIC g818014ex99_2p28g1.jpg GRAPHIC 248170
27 GRAPHIC g818014ex99_2p29g1.jpg GRAPHIC 192408
28 GRAPHIC g818014ex99_2p2g1.jpg GRAPHIC 509719
29 GRAPHIC g818014ex99_2p30g1.jpg GRAPHIC 296922
30 GRAPHIC g818014ex99_2p31g1.jpg GRAPHIC 61429
31 GRAPHIC g818014ex99_2p32g1.jpg GRAPHIC 191718
32 GRAPHIC g818014ex99_2p33g1.jpg GRAPHIC 224247
33 GRAPHIC g818014ex99_2p34g1.jpg GRAPHIC 240422
34 GRAPHIC g818014ex99_2p35g1.jpg GRAPHIC 173881
35 GRAPHIC g818014ex99_2p36g1.jpg GRAPHIC 280859
36 GRAPHIC g818014ex99_2p37g1.jpg GRAPHIC 139482
37 GRAPHIC g818014ex99_2p38g1.jpg GRAPHIC 235307
38 GRAPHIC g818014ex99_2p3g1.jpg GRAPHIC 225902
39 GRAPHIC g818014ex99_2p4g1.jpg GRAPHIC 177750
40 GRAPHIC g818014ex99_2p5g1.jpg GRAPHIC 224915
41 GRAPHIC g818014ex99_2p6g1.jpg GRAPHIC 179286
42 GRAPHIC g818014ex99_2p7g1.jpg GRAPHIC 184755
43 GRAPHIC g818014ex99_2p8g1.jpg GRAPHIC 219743
44 GRAPHIC g818014ex99_2p9g1.jpg GRAPHIC 226096
45 GRAPHIC g818014g0926193456156.jpg GRAPHIC 2535
  Complete submission text file 0001193125-24-272891.txt   11907905

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vor-20241209.xsd EX-101.SCH 2835
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20241209_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20241209_pre.xml EX-101.PRE 11698
56 EXTRACTED XBRL INSTANCE DOCUMENT d818014d8k_htm.xml XML 3767
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 241533861
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)